Analysen zu Novartis AG
| 22.03.24 | Novartis Buy | Deutsche Bank AG | |
| 07.02.24 | Novartis Buy | Deutsche Bank AG | |
| 07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | Novartis Underweight | Barclays Capital | |
| 06.02.24 | Novartis Buy | UBS AG | |
| 05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.02.24 | Novartis Buy | Deutsche Bank AG | |
| 31.01.24 | Novartis Kaufen | DZ BANK | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 05.01.24 | Novartis Buy | Deutsche Bank AG | |
| 03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 21.12.23 | Novartis Underweight | Barclays Capital | |
| 19.12.23 | Novartis Buy | Deutsche Bank AG | |
| 05.12.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.11.23 | Novartis Buy | Deutsche Bank AG | |
| 29.11.23 | Novartis Underweight | Barclays Capital | |
| 28.11.23 | Novartis Neutral | UBS AG | |
| 28.11.23 | Novartis Buy | Jefferies & Company Inc. | |
| 27.11.23 | Novartis Buy | Deutsche Bank AG | |
| 26.10.23 | Novartis Buy | Deutsche Bank AG | |
| 24.10.23 | Novartis Neutral | UBS AG | |
| 24.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 23.10.23 | Novartis Underweight | Barclays Capital | |
| 19.10.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.10.23 | Novartis Buy | Deutsche Bank AG | |
| 04.10.23 | Novartis Neutral | UBS AG | |
| 04.10.23 | Novartis Buy | Deutsche Bank AG | |
| 03.10.23 | Novartis Buy | Deutsche Bank AG | |
| 26.09.23 | Novartis Buy | Deutsche Bank AG | |
| 25.09.23 | Novartis Equal-weight | Morgan Stanley | |
| 22.09.23 | Novartis Buy | Deutsche Bank AG | |
| 08.09.23 | Novartis Buy | Deutsche Bank AG | |
| 05.09.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.09.23 | Novartis Buy | Deutsche Bank AG | |
| 31.08.23 | Novartis Buy | Deutsche Bank AG | |
| 31.08.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.08.23 | Novartis Buy | Deutsche Bank AG | |
| 10.08.23 | Novartis Underweight | Barclays Capital | |
| 19.07.23 | Novartis Buy | Deutsche Bank AG | |
| 19.07.23 | Novartis Neutral | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 24.04.25 | HUGO BOSS Hold | Deutsche Bank AG | |
| 24.04.25 | Volvo AB Buy | Deutsche Bank AG | |
| 24.04.25 | Eni Overweight | JP Morgan Chase & Co. | |
| 24.04.25 | ASOS Hold | Jefferies & Company Inc. | |
| 24.04.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 24.04.25 | KRONES Buy | Deutsche Bank AG | |
| 24.04.25 | Commerzbank Buy | Deutsche Bank AG | |
| 24.04.25 | Nestlé Add | Baader Bank | |
| 24.04.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 24.04.25 | BNP Paribas Overweight | Barclays Capital | |
| 24.04.25 | Verbund verkaufen | Deutsche Bank AG | |
| 24.04.25 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 24.04.25 | Kering Market-Perform | Bernstein Research | |
| 24.04.25 | Saint-Gobain Neutral | UBS AG | |
| 24.04.25 | Heidelberg Materials Neutral | UBS AG | |
| 24.04.25 | Danone Buy | UBS AG | |
| 24.04.25 | Reckitt Benckiser Buy | UBS AG | |
| 24.04.25 | Siemens Energy Buy | Goldman Sachs Group Inc. | |
| 24.04.25 | Kering Sell | Goldman Sachs Group Inc. | |
| 24.04.25 | Boeing Buy | Goldman Sachs Group Inc. | |
| 24.04.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 24.04.25 | Danone Neutral | Goldman Sachs Group Inc. | |
| 24.04.25 | Vossloh Buy | Jefferies & Company Inc. | |
| 24.04.25 | Nokia Underweight | Barclays Capital | |
| 24.04.25 | NVIDIA Outperform | Bernstein Research | |
| 24.04.25 | Delivery Hero Overweight | Barclays Capital | |
| 24.04.25 | STMicroelectronics Buy | Jefferies & Company Inc. | |
| 24.04.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 24.04.25 | Delivery Hero Buy | Jefferies & Company Inc. | |
| 24.04.25 | BNP Paribas Buy | Jefferies & Company Inc. | |
| 24.04.25 | Nokia Hold | Jefferies & Company Inc. | |
| 24.04.25 | Air Liquide Buy | Jefferies & Company Inc. | |
| 24.04.25 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 24.04.25 | Roche Hold | Jefferies & Company Inc. | |
| 24.04.25 | EVOTEC Hold | Deutsche Bank AG | |
| 24.04.25 | adidas Equal Weight | Barclays Capital | |
| 24.04.25 | Renault Hold | Jefferies & Company Inc. | |
| 24.04.25 | Adyen B.V. Parts Sociales Buy | UBS AG | |
| 24.04.25 | Siemens Energy Hold | Jefferies & Company Inc. | |
| 24.04.25 | Siemens Buy | Jefferies & Company Inc. | |
| 24.04.25 | Boeing Outperform | RBC Capital Markets | |
| 24.04.25 | L'Oréal Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.04.25 | SAP Overweight | Barclays Capital | |
| 24.04.25 | QIAGEN Neutral | UBS AG | |
| 24.04.25 | Danone Overweight | JP Morgan Chase & Co. | |
| 24.04.25 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
| 24.04.25 | SAP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.04.25 | EssilorLuxottica Neutral | UBS AG | |
| 24.04.25 | Kering Hold | Jefferies & Company Inc. | |
| 24.04.25 | SAP Overweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.